BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 15470401)

  • 21. Syngenta ready to drop plans for Indian rice venture.
    Jayaraman KS
    Nature; 2002 Dec; 420(6916):596. PubMed ID: 12478254
    [No Abstract]   [Full Text] [Related]  

  • 22. The greater good.
    Nature; 2014 Jan; 505(7481):5. PubMed ID: 24380932
    [No Abstract]   [Full Text] [Related]  

  • 23. UK research funding.
    Nat Cell Biol; 2009 Apr; 11(4):363. PubMed ID: 19337316
    [No Abstract]   [Full Text] [Related]  

  • 24. University-industry collaboration. Last of the big-time spenders?
    Lawler A
    Science; 2003 Jan; 299(5605):330-3. PubMed ID: 12531991
    [No Abstract]   [Full Text] [Related]  

  • 25. Start up and succeed.
    Kaplan K
    Nature; 2009 Nov; 462(7272):530-1. PubMed ID: 20066758
    [No Abstract]   [Full Text] [Related]  

  • 26. Scientists attack industrial influence.
    Knight J
    Nature; 2003 Dec; 426(6968):741. PubMed ID: 14685179
    [No Abstract]   [Full Text] [Related]  

  • 27. Conflicts of interest at the NIH: no easy solution.
    Resnik DB
    Hastings Cent Rep; 2005; 35(1):18-20. PubMed ID: 15799496
    [No Abstract]   [Full Text] [Related]  

  • 28. Science budget: funding by numbers.
    Gould J
    Nature; 2014 Jul; 511(7510):S52-3. PubMed ID: 25054851
    [No Abstract]   [Full Text] [Related]  

  • 29. Industry links boost research output.
    Savage N
    Nature; 2017 Dec; 552(7683):S11-S13. PubMed ID: 29220000
    [No Abstract]   [Full Text] [Related]  

  • 30. Boom and bust plagues Pakistan's universities.
    Brumfiel G; Inman M
    Nature; 2010 Sep; 467(7314):378-9. PubMed ID: 20864966
    [No Abstract]   [Full Text] [Related]  

  • 31. Cancer researcher found guilty of negligence.
    Schiermeier Q
    Nature; 2002 Nov; 420(6913):258. PubMed ID: 12447407
    [No Abstract]   [Full Text] [Related]  

  • 32. Q&A Jane Harding: individual approach.
    Harding J; Mallapaty S
    Nature; 2014 Jul; 511(7510):S82-3. PubMed ID: 25054858
    [No Abstract]   [Full Text] [Related]  

  • 33. Seizing the moment.
    Nature; 2010 Sep; 467(7313):251. PubMed ID: 20844490
    [No Abstract]   [Full Text] [Related]  

  • 34. Universities could gain from backing biotech.
    Kamb A
    Nature; 2003 Mar; 422(6928):113. PubMed ID: 12634753
    [No Abstract]   [Full Text] [Related]  

  • 35. Intellectual property rights.
    Ogle W
    Science; 2000 May; 288(5469):1173-4. PubMed ID: 10841736
    [No Abstract]   [Full Text] [Related]  

  • 36. Commercializing university research. Lessons from the experience of the Wisconsin Alumni Research Foundation.
    Blumenthal D; Epstein S; Maxwell J
    N Engl J Med; 1986 Jun; 314(25):1621-6. PubMed ID: 3713759
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Europe pays the price for spending less.
    Patten L
    Nature; 2006 Jun; 441(7094):691-3. PubMed ID: 16760956
    [No Abstract]   [Full Text] [Related]  

  • 38. Developing an intellectual property portfolio for the academic or not-for-profit institution.
    Bloomberg CA
    Nat Biotechnol; 2005 Jan; 23(1):119-21. PubMed ID: 15637626
    [No Abstract]   [Full Text] [Related]  

  • 39. Use of NIH funds placed under a spotlight.
    Marris E
    Nature; 2005 Sep; 437(7059):601. PubMed ID: 16193003
    [No Abstract]   [Full Text] [Related]  

  • 40. Greek science on the brink.
    Abbott A
    Nature; 2012 Jan; 481(7380):123-4. PubMed ID: 22237082
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.